HK1069170A1 - A process for the preparation of the 14beta-hydroxy-baccatin iii-1, 14-carbonate - Google Patents

A process for the preparation of the 14beta-hydroxy-baccatin iii-1, 14-carbonate

Info

Publication number
HK1069170A1
HK1069170A1 HK05101660A HK05101660A HK1069170A1 HK 1069170 A1 HK1069170 A1 HK 1069170A1 HK 05101660 A HK05101660 A HK 05101660A HK 05101660 A HK05101660 A HK 05101660A HK 1069170 A1 HK1069170 A1 HK 1069170A1
Authority
HK
Hong Kong
Prior art keywords
preparation
14beta
hydroxy
carbonate
baccatin iii
Prior art date
Application number
HK05101660A
Other languages
English (en)
Inventor
Ezio Bombardelli
Gabriele Fontana
Maria Luisa Gelmi
Donato Pocar
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HK1069170A1 publication Critical patent/HK1069170A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK05101660A 2001-10-19 2005-02-28 A process for the preparation of the 14beta-hydroxy-baccatin iii-1, 14-carbonate HK1069170A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI002186A ITMI20012186A1 (it) 2001-10-19 2001-10-19 Procedimento per la preparazione della 14-beta-idrossi-baccatina iii-1,14-carbonato
PCT/EP2002/008005 WO2003035633A1 (en) 2001-10-19 2002-07-18 A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate

Publications (1)

Publication Number Publication Date
HK1069170A1 true HK1069170A1 (en) 2005-05-13

Family

ID=11448529

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05101660A HK1069170A1 (en) 2001-10-19 2005-02-28 A process for the preparation of the 14beta-hydroxy-baccatin iii-1, 14-carbonate

Country Status (20)

Country Link
US (1) US7078432B2 (xx)
EP (1) EP1436277B1 (xx)
JP (1) JP4454310B2 (xx)
KR (1) KR100896542B1 (xx)
CN (1) CN1271061C (xx)
AT (1) ATE537160T1 (xx)
AU (1) AU2002328918B2 (xx)
BR (1) BR0213360B1 (xx)
CA (1) CA2463915C (xx)
DK (1) DK1436277T3 (xx)
ES (1) ES2376162T3 (xx)
HK (1) HK1069170A1 (xx)
HU (1) HUP0401989A3 (xx)
IL (1) IL161443A0 (xx)
IT (1) ITMI20012186A1 (xx)
MX (1) MXPA04003519A (xx)
NO (1) NO328562B1 (xx)
PL (1) PL368122A1 (xx)
RU (1) RU2291866C2 (xx)
WO (1) WO2003035633A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato
ITMI20021921A1 (it) * 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
ES2389518T3 (es) 2008-01-18 2012-10-26 Indena S.P.A. Formas sólidas de ortataxel
CN103450118A (zh) * 2013-09-18 2013-12-18 江苏红豆杉药业有限公司 一种半合成法制备紫杉醇的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254517B (it) * 1992-03-06 1995-09-25 Indena Spa 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
US5475011A (en) 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
IT1275936B1 (it) * 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
FR2732341A1 (fr) * 1995-03-27 1996-10-04 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
IT1275435B (it) 1995-05-19 1997-08-07 Indena Spa Derivati della 10-desacetil-14beta-idrossibaccatina iii,loro metodo di preparazione e formulazioni che li contengono
IT1283633B1 (it) * 1996-05-10 1998-04-23 Indena Spa Derivati tassanici loro sintesi e formulazioni che li contengono
US5811452A (en) * 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
IT1318678B1 (it) 2000-08-10 2003-08-27 Indena Spa Procedimento per la preparazione di derivati della baccatina iii.
IT1320107B1 (it) * 2000-11-28 2003-11-18 Indena Spa Procedimento per la preparazione di derivati tassanici.
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato

Also Published As

Publication number Publication date
RU2291866C2 (ru) 2007-01-20
NO328562B1 (no) 2010-03-22
WO2003035633A1 (en) 2003-05-01
JP2005512977A (ja) 2005-05-12
EP1436277A1 (en) 2004-07-14
DK1436277T3 (da) 2012-01-23
JP4454310B2 (ja) 2010-04-21
MXPA04003519A (es) 2004-07-23
ES2376162T3 (es) 2012-03-09
CN1271061C (zh) 2006-08-23
CA2463915C (en) 2009-11-24
HUP0401989A3 (en) 2007-05-29
ATE537160T1 (de) 2011-12-15
US20040266859A1 (en) 2004-12-30
KR100896542B1 (ko) 2009-05-07
ITMI20012186A1 (it) 2003-04-19
IL161443A0 (en) 2004-09-27
BR0213360B1 (pt) 2014-04-15
HUP0401989A2 (hu) 2005-01-28
RU2004111669A (ru) 2005-04-20
NO20041537L (no) 2004-04-15
CA2463915A1 (en) 2003-05-01
EP1436277B1 (en) 2011-12-14
CN1571779A (zh) 2005-01-26
PL368122A1 (en) 2005-03-21
US7078432B2 (en) 2006-07-18
AU2002328918B2 (en) 2008-09-04
KR20040045023A (ko) 2004-05-31
BR0213360A (pt) 2004-10-26

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
UA87710C2 (ru) Способ получения производных [1,4,5]-оксадиазепина
HK1088325A1 (en) Process for the preparation of baccatin III derivatives
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
IL185920A0 (en) A process for the preparation of the 14beta-hydroxy-baccatin iii-1, 14-carbonate
HK1069170A1 (en) A process for the preparation of the 14beta-hydroxy-baccatin iii-1, 14-carbonate
WO2001002407A3 (en) Taxane derivatives and processes for the preparation thereof
IL156141A0 (en) A process for the preparation of taxan derivatives
MXPA03011401A (es) Procedimiento para la preparacion de derivados de ciclohexanol.
DE60107238D1 (en) Stolonoxide
IL161800A0 (en) Method for the production of desclarithromycin, and intermediateproducts

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210715